DDIT3 and liposarcoma: To translate our findings in genetically engineered SCP‐1 cells to the setting of endogenous FUS‐DDIT3 expression, we first determined YAP1 mRNA and protein levels in a panel of human liposarcoma cell lines using quantitative RT–PCR and immunoblotting.